Mathilde Moazazi, MD
Emergency Medicine · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 3 carriers
- Offices
- 4
Offices
4 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
7 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Moazazi’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C151881 · Current
Licensed to practise in California · since 2017 · expires 2026-10-31 · University of Pavia Faculty of Medicine and Surgery.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$18,189
Medicare paid this office $18,189 for 146 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Emergency department visit with high level of medical decision making | 60 | $7,789 | $128 |
| Return visit (30+ min) | 44 | $4,378 | $73 |
| New patient visit (45+ min) | 13 | $953 | $73 |
| Emergency department visit with moderate level of medical decision making | 11 | $833 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 57 | $361 | $6 |
Who their Medicare patients are
146 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 10% · Women 60% · Also on Medicaid 35% · Health risk score 1.13. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 69% · Diabetes 27% · Coronary heart disease 27% · Depression 22% · Atrial fibrillation 21% · Heart failure 17% · COPD 17% · Chronic kidney disease 16% · Cancer 15% · Stroke 13% · Dementia 8%.
The office billed $152,056, Medicare allowed $28,200 and paid $18,189; for 242 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 146 | 242 | 73 | 1.13 | $152,056 | $18,189 |
| 2023 | 244 | 668 | 75 | 1.28 | $257,613 | $58,324 |
| 2022 | 101 | 225 | 76 | 0.99 | $72,825 | $20,128 |
| 2020 | 20 | 28 | 79 | 1.13 | $9,055 | $1,201 |
| 2019 | 105 | 362 | 76 | 1.26 | $112,917 | $29,560 |
| 2018 | 193 | 304 | 72 | 2.08 | $221,009 | $26,539 |
| 2017 | 490 | 615 | 66 | 3.05 | $726,399 | $62,255 |
| 2016 | 560 | 843 | 66 | 3.07 | $254,529 | $70,409 |
| 2015 | 399 | 533 | 66 | 2.94 | $171,787 | $48,549 |
| 2014 | 249 | 295 | 67 | 2.27 | $161,971 | $28,234 |
| 2013 | 795 | 1,001 | 69 | 1.69 | $729,923 | $97,989 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 119 | $16,324 | $74 |
| Return visit (30+ min) | 93 | $15,256 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,247 | $142 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $6,199 | $282 |
| Emergency department visit with high level of medical decision making | 17 | $2,339 | $138 |
| New patient visit (30+ min) | 23 | $1,994 | $87 |
| Influenza vaccine split virus, preservative free | 15 | $1,151 | $72 |
| Administration of influenza virus vaccine | 22 | $887 | $37 |
| Administration of pneumococcal vaccine | 21 | $813 | $37 |
| Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | 18 | $127 | $7 |
| Urinalysis, manual test | 15 | $58 | $3 |
2022: 3 services
| Short return visit (20+ min) | 50 | $6,037 | $86 |
| Return visit (30+ min) | 36 | $4,945 | $118 |
| Administration of influenza virus vaccine | 18 | $670 | $37 |
2020: 1 service
| Return visit (30+ min) | 18 | $621 | $35 |
2019: 6 services
| Return visit (30+ min) | 90 | $20,098 | $93 |
| Pneumococcal vaccine, 13-valent | 11 | $2,311 | $210 |
| Short return visit (20+ min) | 17 | $839 | $47 |
| Influenza vaccine split virus, preservative free | 14 | $768 | $55 |
| Administration of influenza virus vaccine | 14 | $308 | $21 |
| Administration of pneumococcal vaccine | 14 | $287 | $21 |
2018: 6 services
| Return visit (30+ min) | 60 | $8,785 | $99 |
| Emergency department visit with high level of medical decision making | 56 | $6,605 | $118 |
| Emergency department visit with moderate level of medical decision making | 38 | $2,863 | $73 |
| Short return visit (20+ min) | 32 | $2,429 | $62 |
| Emergency department visit with low level of medical decision making | 13 | $562 | $43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $65 | $6 |
2017: 5 services
| Emergency department visit with high level of medical decision making | 319 | $42,597 | $128 |
| Emergency department visit with moderate level of medical decision making | 115 | $10,290 | $84 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 23 | $2,477 | $108 |
| Emergency department visit with low level of medical decision making | 54 | $2,341 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $226 | $6 |
2016: 6 services
| Emergency department visit with high level of medical decision making | 352 | $47,417 | $128 |
| Emergency department visit with moderate level of medical decision making | 166 | $13,973 | $83 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 26 | $2,127 | $82 |
| Emergency department visit with low level of medical decision making | 44 | $2,015 | $44 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 16 | $1,473 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 174 | $1,260 | $6 |
2015: 6 services
| Emergency department visit with high level of medical decision making | 231 | $30,104 | $129 |
| Emergency department visit with moderate level of medical decision making | 111 | $9,265 | $83 |
| Critical care, first 30-74 minutes | 25 | $4,381 | $168 |
| Emergency department visit with low level of medical decision making | 26 | $1,310 | $47 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,202 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 65 | $638 | $6 |
2014: 4 services
| Emergency department visit with high level of medical decision making | 143 | $17,869 | $124 |
| Emergency department visit with moderate level of medical decision making | 77 | $6,425 | $81 |
| Emergency department visit with low level of medical decision making | 17 | $754 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $200 | $6 |
2013: 7 services
| Emergency department visit with high level of medical decision making | 395 | $51,222 | $121 |
| Emergency department visit with moderate level of medical decision making | 228 | $19,569 | $82 |
| Critical care, first 30-74 minutes | 92 | $15,482 | $161 |
| Emergency department visit with low level of medical decision making | 143 | $6,249 | $42 |
| Critical care, each additional 30 minutes | 29 | $2,501 | $81 |
| Emergency department visit with straightforward medical decision making | 11 | $257 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $85 | $6 |
Medicaid work
$22,112 in 2024
Medicaid paid $22,112 for 467 billed services this clinician did in 2024, up to 45 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPT VISIT MOD MDM | 238 | $12,308 |
| Service | 57 | $4,676 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 63 | $4,607 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 34 | $294 |
| Return visit (30+ min) | 27 | $71 |
| New patient visit (30+ min) | 12 | $66 |
| COMPREHENSIVE METABOLIC PANEL | 12 | $45 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 24 | $44 |
| 2024 | 467 | 8 | 45 | $22,112 |
| 2023 | 65 | 2 | 24 | $4,488 |
| 2020 | 29 | 1 | 22 | $0 |
| 2019 | 133 | 1 | 19 | $0 |
| 2018 | 1,836 | 26 | 90 | $98,287 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPT VISIT MOD MDM | 53 | $3,947 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 12 | $540 |
2020
| Return visit (30+ min) | 29 | $0 |
2019
| Return visit (30+ min) | 133 | $0 |
2018
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 247 | $39,160 |
| EMERGENCY DEPT VISIT MOD MDM | 320 | $37,851 |
| EMERGENCY DEPT VISIT LOW MDM | 246 | $16,961 |
| Computed tomography, head or brain; without contrast material | 15 | $595 |
| Troponin, quantitative | 63 | $580 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 51 | $520 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 130 | $458 |
| COMPREHENSIVE METABOLIC PANEL | 128 | $331 |
| Radiologic examination, chest; 2 views | 65 | $255 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 61 | $229 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 26 | $226 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 17 | $217 |
Drugs they prescribed that Part D paid
$68,227
Pharmacies billed $68,227 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,004 generic and fewer than 11 brand-name prescriptions · $68,227 in drug cost · 256 antibiotic prescriptions to 206 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 57 | $1,134 | $20 |
| Estradiol | 13 | $553 | $43 |
| Rosuvastatin | 20 | $531 | $27 |
| Levothyroxine | 38 | $488 | $13 |
| Atorvastatin | 45 | $389 | $9 |
See all 27 drugs
| Albuterol Sulfate Hfa | 57 | $1,134 | $20 |
| Estradiol | 13 | $553 | $43 |
| Rosuvastatin | 20 | $531 | $27 |
| Levothyroxine | 38 | $488 | $13 |
| Atorvastatin | 45 | $389 | $9 |
| Losartan | 21 | $384 | $18 |
| Azithromycin | 54 | $340 | $6 |
| Omeprazole | 23 | $331 | $14 |
| Doxycycline Monohydrate | 30 | $268 | $9 |
| Amoxicillin-Clavulanate Potass | 41 | $260 | $6 |
| Simvastatin | 17 | $247 | $15 |
| Bupropion Xl | 13 | $245 | $19 |
| Metoprolol | 16 | $231 | $14 |
| Montelukast | 15 | $207 | $14 |
| Metformin | 24 | $180 | $8 |
| Cephalexin | 41 | $178 | $4 |
| Prednisone | 93 | $176 | $2 |
| Fluticasone Propionate | 17 | $157 | $9 |
| Gabapentin | 18 | $150 | $8 |
| Lisinopril | 14 | $136 | $10 |
| Famotidine | 16 | $115 | $7 |
| Alendronate | 14 | $111 | $8 |
| Erythromycin | 11 | $111 | $10 |
| Sulfamethoxazole-Trimethoprim | 43 | $107 | $2 |
| Amlodipine Besylate | 12 | $106 | $9 |
| Amoxicillin | 18 | $53 | $3 |
| Cyclobenzaprine | 13 | $25 | $2 |
Year by year
| 2024 | 1,144 | 408 | None | None | $68,227 |
| 2023 | 1,141 | 251 | 2% (18) | 11% | $129,262 |
| 2022 | 369 | 168 | 4% (13) | 5% | $18,710 |
| 2021 | 174 | 114 | 8% (14) | None | $3,520 |
| 2020 | 450 | 195 | 6% (25) | 10% | $17,744 |
| 2019 | 851 | 167 | 2% (18) | None | $55,298 |
| 2018 | 299 | 131 | 12% (36) | 12% | $7,598 |
| 2017 | 284 | 182 | 28% (78) | 8% | $4,204 |
| 2016 | 243 | 141 | 30% (72) | 12% | $2,485 |
| 2015 | 225 | 95 | 16% (35) | None | $5,405 |
| 2014 | 165 | 44 | None | None | $4,474 |
| 2013 | 452 | 189 | 15% (66) | 15% | $16,069 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Xifaxan | 11 | $38,841 | $3,531 |
| Eliquis | 11 | $17,527 | $1,593 |
| Lactulose | 34 | $1,009 | $30 |
| Rosuvastatin | 18 | $823 | $46 |
| Ventolin Hfa | 11 | $677 | $62 |
| Ondansetron | 16 | $663 | $41 |
| Levothyroxine | 42 | $617 | $15 |
| Tamsulosin | 23 | $615 | $27 |
| Montelukast | 21 | $613 | $29 |
| Atorvastatin | 61 | $588 | $10 |
| Gabapentin | 26 | $587 | $23 |
| Albuterol Sulfate Hfa | 18 | $575 | $32 |
| Lisinopril | 25 | $430 | $17 |
| Losartan | 27 | $417 | $15 |
| Bupropion Xl | 18 | $410 | $23 |
| Famotidine | 19 | $376 | $20 |
| Metformin | 45 | $323 | $7 |
| Omeprazole | 20 | $286 | $14 |
| Finasteride | 11 | $253 | $23 |
| Diclofenac | 11 | $245 | $22 |
| Simvastatin | 17 | $245 | $14 |
| Alendronate | 18 | $230 | $13 |
| Carvedilol | 15 | $210 | $14 |
| Sulfamethoxazole-Trimethoprim | 24 | $193 | $8 |
| Hydrocodone-Acetaminophen | 15 | $190 | $13 |
| Paxlovid (Eua) | 17 | $167 | $10 |
| Amlodipine Besylate | 18 | $161 | $9 |
| Azithromycin | 14 | $145 | $10 |
| Ciprofloxacin | 12 | $110 | $9 |
| Pantoprazole | 12 | $90 | $7 |
| Trazodone | 13 | $77 | $6 |
| Hydrochlorothiazide | 14 | $76 | $5 |
| Cephalexin | 12 | $63 | $5 |
| Prednisone | 26 | $38 | $1 |
| Alprazolam | 15 | $29 | $2 |
2022: 11 drugs
| Lactulose | 14 | $268 | $19 |
| Amoxicillin-Clavulanate Potass | 19 | $204 | $11 |
| Azithromycin | 21 | $180 | $9 |
| Paxlovid (Eua) | 12 | $117 | $10 |
| Metronidazole | 13 | $96 | $7 |
| Sulfamethoxazole-Trimethoprim | 21 | $90 | $4 |
| Ciprofloxacin | 17 | $85 | $5 |
| Cephalexin | 18 | $79 | $4 |
| Hydrocodone-Acetaminophen | 11 | $75 | $7 |
| Prednisone | 33 | $59 | $2 |
| Amoxicillin | 11 | $45 | $4 |
2021: 5 drugs
| Cephalexin | 16 | $87 | $5 |
| Metronidazole | 11 | $85 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $77 | $5 |
| Ciprofloxacin | 11 | $65 | $6 |
| Hydrocodone-Acetaminophen | 12 | $36 | $3 |
2020: 10 drugs
| Metronidazole | 19 | $422 | $22 |
| Levothyroxine | 15 | $340 | $23 |
| Alendronate | 14 | $198 | $14 |
| Ondansetron | 14 | $176 | $13 |
| Sulfamethoxazole-Trimethoprim | 40 | $135 | $3 |
| Metformin | 18 | $135 | $7 |
| Cephalexin | 17 | $84 | $5 |
| Acetaminophen-Codeine | 21 | $68 | $3 |
| Ciprofloxacin | 18 | $62 | $3 |
| Naproxen | 13 | $27 | $2 |
2019: 24 drugs
| Eliquis | 14 | $3,027 | $216 |
| Levothyroxine | 54 | $895 | $17 |
| Ventolin Hfa | 11 | $811 | $74 |
| Loperamide | 21 | $477 | $23 |
| Finasteride | 15 | $444 | $30 |
| Atorvastatin | 25 | $339 | $14 |
| Fluoxetine | 13 | $298 | $23 |
| Alendronate | 21 | $283 | $13 |
| Metformin | 42 | $262 | $6 |
| Pantoprazole | 18 | $241 | $13 |
| Lactulose | 21 | $228 | $11 |
| Gabapentin | 19 | $202 | $11 |
| Losartan | 16 | $181 | $11 |
| Fluticasone Propionate | 13 | $163 | $13 |
| Ciprofloxacin | 25 | $152 | $6 |
| Sulfamethoxazole-Trimethoprim | 34 | $131 | $4 |
| Meclizine | 11 | $122 | $11 |
| Simvastatin | 20 | $118 | $6 |
| Metronidazole | 14 | $117 | $8 |
| Atenolol | 18 | $103 | $6 |
| Diazepam | 12 | $90 | $7 |
| Lisinopril | 13 | $87 | $7 |
| Amoxicillin | 12 | $62 | $5 |
| Alprazolam | 17 | $56 | $3 |
2018: 7 drugs
| Levothyroxine | 16 | $174 | $11 |
| Hydrocodone-Acetaminophen | 12 | $140 | $12 |
| Gabapentin | 13 | $128 | $10 |
| Metronidazole | 11 | $127 | $12 |
| Acetaminophen-Codeine | 22 | $85 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $63 | $5 |
| Prednisone | 14 | $46 | $3 |
2017: 5 drugs
| Proair Hfa | 13 | $760 | $58 |
| Azithromycin | 18 | $196 | $11 |
| Acetaminophen-Codeine | 72 | $193 | $3 |
| Prednisone | 34 | $112 | $3 |
| Sulfamethoxazole-Trimethoprim | 21 | $77 | $4 |
2016: 5 drugs
| Acetaminophen-Codeine | 64 | $192 | $3 |
| Ondansetron | 20 | $101 | $5 |
| Prednisone | 22 | $83 | $4 |
| Furosemide | 15 | $62 | $4 |
| Sulfamethoxazole-Trimethoprim | 15 | $52 | $3 |
2015: 6 drugs
| Vytorin | 20 | $2,291 | $115 |
| Furosemide | 46 | $216 | $5 |
| Ondansetron | 13 | $108 | $8 |
| Acetaminophen-Codeine | 24 | $71 | $3 |
| Prednisone | 16 | $64 | $4 |
| Hydrocodone-Acetaminophen | 11 | $47 | $4 |
2014: 4 drugs
| Vytorin | 23 | $2,223 | $97 |
| Furosemide | 46 | $252 | $5 |
| Donepezil | 12 | $145 | $12 |
| Simvastatin | 12 | $123 | $10 |
2013: 15 drugs
| Vytorin | 23 | $1,920 | $83 |
| Dilantin | 13 | $881 | $68 |
| Potassium Chloride | 20 | $300 | $15 |
| Carbidopa-Levodopa | 12 | $300 | $25 |
| Furosemide | 45 | $243 | $5 |
| Azithromycin | 16 | $218 | $14 |
| Donepezil | 12 | $196 | $16 |
| Ciprofloxacin | 11 | $191 | $17 |
| Omeprazole | 12 | $159 | $13 |
| Simvastatin | 15 | $156 | $10 |
| Acetaminophen-Codeine | 27 | $142 | $5 |
| Sulfamethoxazole-Trimethoprim | 21 | $126 | $6 |
| Hydrocodone-Acetaminophen | 30 | $110 | $4 |
| Amoxicillin | 16 | $95 | $6 |
| Prednisone | 21 | $48 | $2 |
Money from drug and device companies
$74 in 2023
| 2023 | 1 | 1 | None | $74 |
| 2022 | 1 | 1 | None | $93 |
| 2019 | 5 | 8 | None | $410 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Arexvy | $74 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2023-08-23 | Arexvy | $74 |
See earlier years (2022, 2019)
2022: $93
| GlaxoSmithKline | Shingrix | $93 | 1 payment
|
2019: $410
| Lilly USA | Jardiance | $129 | 4 payments
|
| CooperSurgical | Paragard | $121 | 1 payment
|
| Boston Scientific | General Therapies | $110 | 1 payment
|
| Amgen | Evenity | $32 | 1 payment
|
| Relypsa | Veltassa | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366671224
- Licence
- AR E6792, CA CA151881California C151881: Current · expires 2026-10-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 444 Bruce St, Yreka, CA, 96097
- NPI first listed
- 2009-07-13
- NPI last updated
- 2023-09-29
- NPI record certified
- 2023-09-29
This is when the NPI record was last certified, not a medical board exam.